Skip to search formSkip to main contentSkip to account menu

Phosphodiesterase 3 Inhibitor [EPC]

Known as: Phosphodiesterase 3 Inhibitor, Phosphodiesterase III Inhibitor 
National Institutes of Health

Related topics

Related topics

2 relations
Phosphodiesterase 3 InhibitorsPhosphodiesterase 3 Inhibitors [MoA]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Effects of chronic treatment with cilostazol, a phosphodiesterase 3 inhibitor, on female rat bladder in a partial bladder outlet obstruction model.
Review
2010
Review
2010
Dual antiplatelet therapy in the secondary prevention of atherothrombosis: need for new therapeutic approaches.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)